O
ALEC icon

OrbiMed’s Alector ALEC Stock Holding History

OrbiMed’s Portfolio ALEC Stock Details ALEC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-611,478
Closed -$12.7M – 173
2021
Q2 		$12.7M Hold
611,478
– – 0.13% 114
2021
Q1 		$12.3M Sell
611,478
-1,613,835
-73% -$28.9M 0.12% 115
2020
Q4 		$33.6M Sell
2,225,313
-500,000
-18% -$6.21M 0.29% 79
2020
Q3 		$28.7M Sell
2,725,313
-3,250,009
-54% -$52.6M 0.36% 70
2020
Q2 		$146M Sell
5,975,322
-2,352,369
-28% -$64.9M 2.06% 17
2020
Q1 		$201M Sell
8,327,691
-2,660,253
-24% -$67.8M 3.38% 3
2019
Q4 		$189M Sell
10,987,944
-1,544,385
-12% -$26.3M 2.7% 7
2019
Q3 		$181M Sell
12,532,329
-650,000
-5% -$11.7M 3.43% 4
2019
Q2 		$250M Hold
13,182,329
– – 3.88% 5
2019
Q1 		$247M Buy
+13,182,329
New +$249M 3.82% 5

Other funds holding ALEC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

OrbiMed's ALEC Position: Q3 2021 in Review

OrbiMed sold out of Alector (ALEC) in Q3 2021, closing a stake of 611,478 shares — an estimated $12.7M sold.

OrbiMed first reported a position in ALEC in Q1 2019 and held it in 10 quarters. The position peaked at $250M in Q2 2019. 145 funds tracked by Wall St. Rank hold ALEC as of Q3 2021.

  • OrbiMed reported no remaining Alector position as of Q3 2021 after selling out during the quarter.
  • OrbiMed sold 611,478 Alector shares in Q3 2021, an estimated $12.7M.
  • OrbiMed first reported a position in Alector in Q1 2019 and held it in 10 quarters.
  • OrbiMed's Alector position peaked at $250M in Q2 2019.
  • 145 funds tracked by Wall St. Rank held Alector as of Q3 2021.

Based on OrbiMed's 13F filing for Q3 2021, filed 15 Nov 2021.